The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome.
McGinnis
Karen S
KS
Ubriani
Ravi
R
Newton
Sarah
S
Junkins-Hopkins
Jacqueline M
JM
Vittorio
Carmela C
CC
Kim
Ellen J
EJ
Wysocka
Maria
M
Rook
Alain H
AH
D000284:Administration, Oral; D000077610:Bexarotene; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008875:Middle Aged; D017893:Photopheresis; D011994:Recombinant Proteins; D012751:Sezary Syndrome / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene